Covestor’s Zenas BioPharma ZBIO Stock Holding History

Covestor’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	22 +16	+267%	+$318	﹤0.01%	2417
2026 Q1	$0	Buy	+6	New	+$135	﹤0.01%	2872

Other funds holding ZBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Covestor's ZBIO Position: Q2 2026 in Review

Covestor increased its Zenas BioPharma (ZBIO) stake by 267% in Q2 2026, buying an estimated $318 and bringing the position to 22 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Covestor first reported a position in ZBIO in Q1 2026 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

Covestor held 22 shares of Zenas BioPharma worth $1K as of Q2 2026.
Covestor bought 16 Zenas BioPharma shares in Q2 2026, an estimated $318.
Zenas BioPharma made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2417 holding.
Covestor first reported a position in Zenas BioPharma in Q1 2026 and has held it in 2 quarters since.
144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.